Loading clinical trials...
Loading clinical trials...
Evaluation of an Integrated Multicomponent Telemedicine-Based Intervention on Health-Related Quality of Life in Adults With Acute Respiratory Failure Requiring Mechanical Ventilation (Tele-Rehab MV Trial)
To evaluate, through a randomized clinical trial in groups/clusters (stepped wedge), the impact of specific bundles for disability prevention and early rehabilitation, focused on 3 domains (ICU, ward and post-discharge), on health-related quality of life and other long- and short-term outcomes, 90 days after hospital discharge, in critically ill patients affected by hypoxemic acute respiratory failure.
Acute respiratory failure requiring invasive mechanical ventilation is associated with significant mortality rates. Furthermore, survivors often develop new physical, mental, and cognitive disabilities, as well as worsening clinical conditions, which can significantly impair their health-related quality of life. COVID-19 remains a notable cause of acute respiratory failure and long-term disabilities,6 with the added potential to cause persistent symptoms regardless of the infection's initial severity. Although the incidence of SARS-CoV-2-related respiratory failure has declined with the widespread adoption of vaccination, it persists as an endemic cause of pneumonia, particularly among patients with significant comorbidities, and is often part of the differential diagnosis in severe cases of acute hypoxemic respiratory failure. While bundles of interventions including analgesia optimization, sedation minimization, early mobilization, and delirium prevention, as well as screening for individuals at risk of new disabilities for early rehabilitation have been recommended to prevent disabilities in critical care patients, no large randomized clinical trial has yet demonstrated a significant impact on long-term health-related quality of life. Additionally, the burden of disability following critical illness is often associated with patients' inability to attend clinic-based follow-up, and telemedicine may serve as a tool to reduce healthcare inequalities. Accordingly, the primary objective of this cluster stepped-wedge randomized clinical trial is to assess the impact of a multicomponent telemedicine-based intervention on the health-related quality of life of patients with acute hypoxemic respiratory failure requiring invasive mechanical ventilation, evaluated 90 days after hospital discharge.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hospital de Emergência Dr. Daniel Houly
Arapiraca, Alagoas, Brazil
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Manaus, Amazonas, Brazil
Hospital de Messejana Dr. Carlos Alberto Studart Gomes (HM)
Fortaleza, Ceará, Brazil
Hospital Regional Norte - HRN
Sobral, Ceará, Brazil
Hospital Municipal de Salvador
Salvador, Estado de Bahia, Brazil
Hospital Geral de Vitória da Conquista
Vitória da Conquista, Estado de Bahia, Brazil
Hospital Regional de Samambaia
Brasília, Federal District, Brazil
Hospital Municipal Aparecida de Goiania - HMAP
Aparecida de Goiânia, Goiás, Brazil
Hospital Estadual de Doenças Tropicais Dr. Anuar Auad
Goiânia, Goiás, Brazil
Santa Casa de Misericórdia de Belo Horizonte
Belo Horizonte, Minas Gerais, Brazil
Start Date
June 10, 2024
Primary Completion Date
September 5, 2025
Completion Date
September 5, 2025
Last Updated
February 23, 2026
1,916
ACTUAL participants
Standard of Care
BEHAVIORAL
Disability Prevention and Rehabilitation
BEHAVIORAL
Lead Sponsor
Hospital Israelita Albert Einstein
NCT05423301
NCT06750536
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06934876